http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102143951-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67dd1f39f37bac4617e37d6d5c60aa8b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2009-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6d853ae645274532a3f0c2249e53ba2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e75e5890a1317129b73e98a851029469
publicationDate 2011-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102143951-A
titleOfInvention Tri-substituted pyrimidine compounds and their use as PDE10 inhibitors
abstract The present invention provides a tri-substituted pyrimidine compound having an excellent PDE10 inhibitory activity. The present invention relates to a tri-substituted pyrimidine compound represented by the following formula [I0] or a pharmaceutically acceptable salt thereof, a method for preparing the same, and use of said compound for PDE10 inhibitor, and a pharmaceutical composition comprising said compounds as an active ingredient: wherein: either one of X1 and X2 is N, and the other of X1 and X2 is CH; A is *-CH=CH-, *-C(Alk)=CH-, *-CH2-CH2- or *-O-CH2- (* is a bond with R1); Alk is a lower alkyl group; Ring B is an optionally substituted nitrogen-containing aliphatic heterocyclic group; R1 is an optionally substituted quinoxalinyl or an optionally substituted quinolyl; Y0 is mono- or di- substituted amino group, or a pharmaceutically acceptable salt thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103781768-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111018795-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111018795-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103781768-A
priorityDate 2008-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10062508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468375855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID520822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71435789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411224698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID419223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467522020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422114738
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424667332
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58327963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53438558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411222191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465895151
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411224714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466678337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID387928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164070817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411222200
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421105918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468309782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58328046
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465523685
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67250862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87324970
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421155269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420985032
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67251049
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58328055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411223690
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415956071
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467522217

Total number of triples: 64.